Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ: IDXX )

444.53 -15.23 (-3.31%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 5 Years
Via Benzinga
IDEXX Laboratories to Release 2023 First Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
What Does IDEXX Laboratories' Debt Look Like?
Via Benzinga
$100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Analyst Expectations for IDEXX Laboratories's Future
Via Benzinga
$1000 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today
Via Benzinga
What Does IDEXX Laboratories' Debt Look Like?
Via Benzinga
A Look Into IDEXX Laboratories' Debt
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Via Benzinga
2 Top Healthcare Stocks to Buy Right Now
One has a breakout drug, the other a nice-sized moat. 
Via The Motley Fool
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024. 
Via MarketBeat
2 Top Stocks I'm Buying Hand Over Fist in February
Despite underwhelming earnings reports, these businesses remain great investments in 2023. 
Via The Motley Fool
Where IDEXX Laboratories Stands With Analysts
Via Benzinga
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
Via Benzinga
Analyst Says IDEXX Laboratories' Long-Term Growth Outlook Remains Strong
Via Benzinga
Five Best And Worst Performing Healthcare Stocks In January 2023
After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the sector. Let’s take a look at the five best and... 
Via Talk Markets
A Preview Of IDEXX Laboratories's Earnings
Via Benzinga
Golden Cross Appears Before IDEXX Laboratories Investors
Via Benzinga
Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For February 6, 2023
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. 
Via Benzinga
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark
On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier. 
Via Investor's Business Daily
Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge
The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps. 
Via Investor's Business Daily
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better. 
Via Investor's Business Daily
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
GE HealthCare Technologies Soars As GE Legacy Business Plummets
Wednesday marked the trading debut of GE HealthCare Technologies, the health-focused business spun off from General Electric. Shares rose 12%. 
Via MarketBeat
Topics Stocks
Exposures US Equities
What Does IDEXX Laboratories' Debt Look Like?
Shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) moved higher by 28.56% in the past three months. Before having a look at the importance of debt, let's look at how much debt IDEXX Laboratories has. 
Via Benzinga
3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023
By focusing on her interests, I hope to show my daughter that fascinating businesses are all around her. 
Via The Motley Fool
Looking Into IDEXX Laboratories's Return On Capital Employed
Pulled from Benzinga Pro data, IDEXX Laboratories (NASDAQ:IDXX) posted Q3 earnings of $180.94 million, an increase from Q2 of 37.1%. Sales dropped to $841.66 million, a 2.19% decrease between... 
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.